The biotech sector is hotter than it ever was. In a round table discussion, three Flemish protagonists outline the challenges for one of the crown jewels of our economy.
The biotech sector today blows gathering in Ghent for the annual Knowledge for Growth congress. Dart’s interest is massive again, no longer surprised. The successful IPO of Biocartis and the remarkable expansion of major holders such as Galapagos, once again reinforce the perception that biotech is the mecca for the investor, and that there appears to be hardly any dirt in the air for the growth sector for Flanders.

Read more